Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
Active, not recruiting · NCT01979523 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, uveal disorder, uveal melanoma | Active, not recruiting | Phase 2 | 2026-08-06 | NCT01979523 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | Atlanta | United States | 299 |
| Institut Curie Paris | Paris | France | 8 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | New York | United States | 189 |
| The University of Liverpool | Liverpool | United Kingdom | 1 |
| UT MD Anderson Cancer Center | Houston | United States | 204 |
| Vanderbilt University/Ingram Cancer Center | Nashville | United States | 259 |